Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA approves AstraZeneca's SEROQUEL XR Extended-Release Tablets for bipolar disorder
FDA approves AstraZeneca's SEROQUEL XR Extended-Release Tablets for bipolar disorder
FDA approves AstraZeneca's SEROQUEL XR Extended-Release Tablets for bipolar disorder
Submitted by
admin
on October 10, 2008 - 9:30am
Source:
RTT News
Headline:
FDA approves AstraZeneca's SEROQUEL XR Extended-Release Tablets for bipolar disorder
Do Not Allow Advertisers to Use My Personal information
